We are experiencing some temporary issues. The market data on this page are currently delayed. Please bear with us as we address this and restore your personalized lists.

PODD
Insulet Corporation
NasdaqGS
People also watch : DXCM NXTM NUVA HTWR WMGI
32.85 0.04 (0.12%)

After hours: 32.850.00 (0.00%) as of 5:16 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • Max
1d
Prev Close 32.81
Open 33.02
Bid 32.58 x 300
Ask 0.00 x
52wk Range 23.94 - 40.21
Day's Range 32.34 - 33.12
Volume 622,762
Avg Vol (3m) 653,057
As of 4:00 PM EDT. Market closed.
  • 24/7 Wall St. 21 days ago

    A Biotech and a Medical Device Stock, Each With Massive Upside Potential

    Two recent Wedbush research reports focus is on health care companies that not only have data that could prove to be huge, but that have both been absolutely hammered over the past year.

  • Capital Cube last month

    Insulet Corp. – Value Analysis (NASDAQ:PODD) : June 8, 2016

    Click here to see latest analysisCapitalcube gives Insulet Corp. a score of 34.Our analysis is based on comparing Insulet Corp. with the following peers – ICU Medical, Inc., Unilife Corporation, Delcath Systems, Inc., Tandem Diabetes Care, Inc., DexCom, Inc., Medtronic Plc, Eli Lilly and Company, Abbott Laboratories, Johnson & Johnson and Echo Therapeutics, Inc. (ICUI-US, […] (Read more...) The post Insulet Corp. – Value Analysis (NASDAQ:PODD) : June 8, 2016 appeared first on CapitalCube.

  • Capital Cube last month

    Insulet Corp. breached its 50 day moving average in a Bullish Manner : PODD-US : June 7, 2016

    Click here to see latest analysis*Disclaimer : This is as of previous day’s closing price.Technical IndicatorsBelow is a quick look at 5 technical indicators for Insulet Corp.. More studies are available on the Technical Chart.IndicatorSignalClosing Price above/below 50 Day Moving AverageBullishClosing Price above/below 200 Day Moving AverageBullish50 Day Moving Average above/below 200 Day Moving AverageBearishRSI […] (Read more...) The post Insulet Corp. breached its 50 day moving average in a Bullish Manner : PODD-US : June 7, 2016 appeared first on CapitalCube.

  • Insider Monkey 2 months ago

    A Look at Some Noteworthy Insider Purchases and Sales

    With nearly all companies included in the S&P 500 Index having released their earnings reports for the first quarter of 2016, the insider trading activity has been gaining steam in the past several weeks. According to FactSet, the blended first-quarter earnings drop totals 6.8%, which marks the fourth consecutive quarterly earnings decline. It is quite […]

  • Market Realist 2 months ago

    Profit Booking Leaves the iShares US Medical Devices ETF (IHI) in the Red

    On May 19, markets declined, with the SPDR S&P 500 ETF dropping by 0.3% and the iShares US Medical Devices ETF (IHI) declining by 0.8%.

  • Morningstar 2 months ago

    Insulet Shares Swoon on Insurer Decision, but Fair Value Is Unchanged

    We think the firm is largely insulated from UnitedHealth's choice of Medtronic.

  • Capital Cube 2 months ago

    Insulet Corp. breached its 50 day moving average in a Bearish Manner : PODD-US : May 4, 2016

    Click here to see latest analysis*Disclaimer : This is as of previous day’s closing price.Technical IndicatorsBelow is a quick look at 5 technical indicators for Insulet Corp.. More studies are available on the Technical Chart.IndicatorSignalClosing Price above/below 50 Day Moving AverageBearishClosing Price above/below 200 Day Moving AverageBearish50 Day Moving Average above/below 200 Day Moving AverageBullishRSI […] (Read more...) The post Insulet Corp. breached its 50 day moving average in a Bearish Manner : PODD-US : May 4, 2016 appeared first on CapitalCube.

  • Motley Fool 2 months ago

    Why Insulet Corporation and Tandem Diabetes Care Both Tanked Today

    News that a competitor won an exclusive deal with a major payer causes shares to drop.

  • Motley Fool 2 months ago

    Insulet Pumps Out 69% Revenue Growth in Q1, Reaffirms 2016 Guidance

    The leader in tubeless insulin pump technology beat its revenue guidance on strength across all segments. Thanks largely to the success of Amgen’s Neulasta Onpro kit, drug delivery revenue jumped 224%.

  • Capital Cube 2 months ago

    Insulet Corp. :PODD-US: Earnings Analysis: Q1, 2016 By the Numbers

    Click here to see latest analysisInsulet Corp. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of Insulet Corp. – Tandem Diabetes Care, Inc., Medtronic Plc, Eli Lilly and Company, Abbott Laboratories and Johnson & Johnson (TNDM-US, MDT-US, LLY-US, ABT-US and JNJ-US) that have also reported […] (Read more...) The post Insulet Corp. :PODD-US: Earnings Analysis: Q1, 2016 By the Numbers appeared first on CapitalCube.